Contents

Search

lifitegrast (Xiidra)

Indications: - dry eyes (xerophthalmia) Dosage: - 1 drop OU BID (~ q12 hours) - Xiidr (lifitegrast ophthalmic solution) 5% Adverse effects: - eye irritation, discomfort or blurred vision - dysgeusia Mechanism of action: - LFA-1 antagonist

Related

lymphocyte function-associated antigen-1 (LFA-1, leukocyte adhesion protein LFA-1, integrin alpha-L/beta-2, CD11a/CD18)

General

lymphocyte function-associated antigen 1 (LFA-1) antagonist ophthalmic agent (eyedrops)

Database Correlations

PUBCHEM correlations

References

  1. FDA News Release. July 12, 2016 FDA approves new medication for dry eye disease http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm510720.htm
  2. Xiidr Prescribing Information http://www.shirecontent.com/PI/PDFS/XIIDRA_USA_ENG.pdf